Imagine needing a giant library of patient records to train a medical AI, but the books are locked away for privacy. This project creates 'fake' patient data that looks and acts exactly like the real thing but contains no actual people. It's like using a high-quality flight simulator instead of risking a real plane to train a pilot.
Medical AI development is stalled because real patient data is locked behind strict privacy laws and is often incomplete. This creates a bottleneck for companies trying to build personalized treatments and diagnostic tools.
A federated synthetic data publishing platform and a set of generation tools for imaging, genomic, and clinical data. It includes an evaluation system to prove synthetic data is as reliable as real data.
If you are a drug development firm dealing with slow clinical trials and lack of control groups — this project developed synthetic control arms that accelerate trial timelines. This allows for faster validation of therapies for diseases like Lung Cancer and Type 2 Diabetes.
If you are an AI provider dealing with strict GDPR privacy laws that block access to training data — this project developed a federated publishing platform that provides certified synthetic datasets. This enables the creation of diagnostic tools without risking patient privacy breaches.
If you are a radiology startup dealing with a lack of diverse imaging data for rare conditions — this project developed tools for generating realistic synthetic imaging and genomic data. This helps train more robust models for conditions like Multiple Myeloma.
Based on available project data, the project is developing a sustainable publishing platform, but specific pricing models for end-users are not yet disclosed.
Yes, the project uses a federated infrastructure designed to integrate with the European Health Data Space, suggesting a design meant for large-scale European adoption.
Based on available project data, the platform relies on extended open-source frameworks to ensure interoperability and accessibility for the research community.
The project has completed a Data Protection Impact Assessment to ensure all processing is GDPR-compliant and provides an assurance framework for secure use.
The project period runs from 2024-09-01 to 2029-08-31, indicating a multi-year development and validation cycle.
The consortium is heavily weighted toward commercial application, with 19 industry partners representing 49% of the 39 total members. This strong industry presence, combined with partners from 18 countries, suggests the output is being designed for immediate market utility rather than purely academic interest.
Contact Fundacion para la Investigacion del Hospital Universitario La Fe
Contact us to identify potential synthetic data partnerships for your AI pipeline.
